Wolfe Research starts Moderna at Underperform, sees limited upside opportunity
Wolfe Research analyst Alexandria Hammond initiated coverage of Moderna (MRNA) with an Underperform rating and $40 price target Moderna may ...
Wolfe Research starts Regeneron at Outperform, sees ‘attractive entry point’
Wolfe Research initiated coverage of Regeneron (REGN) with an Outperform rating and $1,150 price target Eylea patent litigation concerns had ...
Fintel on MSN11h
Wolfe Research Initiates Coverage of Maravai LifeSciences Holdings (MRVI) with Peer Perform Recommendation
Fintel reports that on November 14, 2024, Wolfe Research initiated coverage of Maravai LifeSciences Holdings (NasdaqGS:MRVI) ...
bovnews16h
SES AI Corp (SES) Stock: Understanding Its Underlying Value
Earlier, on September 5, 2024, Wolfe Research had resumed the stock to Underperform, setting a price target of $1. William Blair also initiated Mkt Perform rating. Additionally, Wolfe Research reduced ...
bovnews18h
RLJ Lodging Trust’s Stock Drama: Could This Be a Game-Changer for RLJ Investors?
On Wednesday, RLJ Lodging Trust (RLJ) stock saw a modest uptick, ending the day at $10.01 which represents a slight increase of $0.07 or 0.70% from the prior close of $9.94. The stock opened at $9.96 ...
Fintel on MSN22h
Wolfe Research Upgrades Phillips Edison (PECO)
Fintel reports that on November 13, 2024, Wolfe Research upgraded their outlook for Phillips Edison (NasdaqGS:PECO) from Peer ...